ZEISS Medical Technology will showcase new ophthalmic innovations within the cataract and corneal refractive workflows at the European Society of Cataract and Refractive Surgery (ESCRS) annual conference from Sept. 8-12, 2023, in Vienna, Austria. As part of the ZEISS Medical Ecosystem, the following enhancements bolster ZEISS’s leadership position in ophthalmic diagnostic and surgical workflow solutions, continuing the company’s transformative progress toward more fully integrated, data-driven healthcare:
- ZEISS elevates the Cataract Workflow with the new AT ELANA® 841P trifocal intraocular lens.
- ZEISS Corneal Refractive Workflow to support presbyopia management.
- ZEISS demonstrates hyperopia indication for SMILE pro.
- New ZEISS ATLAS 500 combines corneal topography and dry eye assessment for improved decision making within the cataract and corneal refractive workflows.
- Refreshed ZEISS VISULAS portfolio offers new therapeutic laser enhancements and connectivity across retina, glaucoma, and cataract clinical workflows.
“Our long-proven legacy of innovation continues to meet the ever-evolving needs of healthcare providers and the billions of patients they serve around the world,” said Euan S. Thomson, Ph.D., President of the Ophthalmology Strategic Business Unit and Head of the Digital Business Unit for ZEISS Medical Technology. “As we continue to extend our position in digital ophthalmic solutions, ZEISS is proud to unveil our latest workflow innovations that are helping to transform the way surgical care is practiced today. We’ll continue to invest in data-driven solutions that enhance clinical decision making and help set new standards of care within the cataract and corneal refractive workflows.”
Elevating the ZEISS Premium Cataract Workflow with a new trifocal IOL
Within the ZEISS Premium Cataract Workflow, cataract surgeons are now offered new cutting-edge technology to boost both clinical and commercial success. The new trifocal intraocular lens (IOL) AT ELANA ® 841P is designed to maximize patient satisfaction by combining leading technologies, including the best of ZEISS trifocal technology on a glistening-free hydrophobic c-loop platform and a fully preloaded injector for a safe and reliable implantation. The ZEISS AT ELANA comes with premium services facilitating patient management and care.
“All my patients implanted with AT ELANA have been very satisfied with uncorrected visual acuity in all three distances,” said Dr. Peter Mojžiš, Ph.D., FEBO, Assistant Professor, Third Faculty, Charles University, Prague. “The fully preloaded injector is very smooth, and the AT ELANA fits through a 2.2mm incision. The controlled unfolding of this new hydrophobic c-loop trifocal IOL and the stability in the capsular bag is excellent. I am very excited about this new addition to the ZEISS IOL portfolio.”
ZEISS Corneal Refractive Workflow to support presbyopia management
At the ESCRS conference, ZEISS will showcase the complete ZEISS Corneal Refractive Workflow for presbyopia management, a condition impacting more than 2 billion people worldwide, highlighting the company’s investment in individualized corneal based solutions. With its customized solutions, ZEISS PRESBYOND addresses individual needs and visual challenges for patients with presbyopia.
Read the full news release from ZEISS.